STOCK TITAN

[Form 4] Synergy CHC Corp. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Alfred Baumeler, who serves as President and a Director of Synergy CHC Corp. (SNYR), reported a stock option grant on 09/18/2025. The grant is for 150,000 options to purchase common stock at an exercise price of $2.38 per share. The filing lists 150,000 shares beneficially owned following the transaction and records ownership as direct. The option has an expiration date shown as 09/18/2030. The grant vests one-third on the first anniversary of the grant date and the remaining two-thirds vest in equal monthly installments over the following 24 months, subject to continued service.

Alfred Baumeler, presidente e un Direttore di Synergy CHC Corp. (SNYR), ha riportato una concessione di stock option in data 09/18/2025. L'assegnazione riguarda 150,000 opzioni per l'acquisto di azioni ordinarie a un prezzo di esercizio di $2.38 per azione. La pratica riporta 150,000 azioni detenute beneficiariamente dopo la transazione e registra la proprietà come diretta. L'opzione ha una data di scadenza indicata come 09/18/2030. La concessione matura un terzo al primo anniversario della data di concessione e i restanti due terzi maturano in rate mensili uguali nei 24 mesi successivi, soggetti al proseguimento del servizio.

Alfred Baumeler, quien se desempeña como Presidente y Director de Synergy CHC Corp. (SNYR), informó una concesión de opciones sobre acciones el 18/09/2025. La concesión es de 150,000 opciones para comprar acciones comunes a un precio de ejercicio de $2.38 por acción. El informe indica que, tras la transacción, se poseen 150,000 acciones de forma beneficiosa y registra la propiedad como directa. La opción tiene una fecha de vencimiento que aparece como 09/18/2030. La concesión se consolida en un tercio al primer aniversario de la fecha de concesión y los dos tercios restantes se consolidan en cuotas mensuales iguales durante los 24 meses siguientes, sujeto a la continuación del servicio.

Alfred Baumeler는 Synergy CHC Corp. (SNYR)의 회장이자 이사로 재직 중이며 2025년 9월 18일에 주식 매수 옵션 부여를 보고했습니다. 이 부여는 150,000개의 일반 주식 매수를 위한 옵션이며 행사 가격은 주당 $2.38입니다. 신고서는 거래 후 150,000주를 유리하게 보유하고 있으며 소유권을 직접으로 기록합니다. 옵션의 만료 날짜는 2025년 9월 18일로 표시됩니다. 부여는 그랜트일의 첫 기념일에 3분의 1이 귀속되고 나머지 2분의 1은 이후 24개월 동안 매월 균등하게 귀속되며 지속적으로 근무하는 조건에 따릅니다.

Alfred Baumeler, qui occupe le poste de président et administrateur de Synergy CHC Corp. (SNYR), a signalé l'attribution d'une option d'achat d'actions le 18/09/2025. L'octroi porte sur 150,000 options d'achat d'actions ordinaires à un prix d'exercice de $2.38 par action. Le dossier indique que 150,000 actions sont détenues de manière bénéficiaire à la suite de l'opération et que la propriété est enregistrée comme directe. L'option expire le 18/09/2030. L'octroi vestit en un tiers au premier anniversaire de la date d'octroi et les deux tiers restants vestissent en versements mensuels égaux sur les 24 mois qui suivent, sous réserve du maintien du service.

Alfred Baumeler, der als Präsident und Director von Synergy CHC Corp. (SNYR) fungiert, meldete eine Aktienoptionszuteilung am 18.09.2025. Die Zuteilung umfasst 150.000 Optionen zum Kauf von Stammaktien zu einem Ausübungspreis von $2.38 pro Aktie. Die Einreichung listet 150.000 anteilig gehaltene Aktien nach der Transaktion auf und vermerkt Eigentum als direkt. Die Option hat ein Ablaufdatum, das als 09/18/2030 angezeigt wird. Die Zuteilung vestiert ein Drittel am ersten Jahrestag des Gewährungsdatums, und die verbleibenden zwei Drittel vestieren in gleichen monatlichen Raten über die folgenden 24 Monate, vorbehaltlich der weiteren Beschäftigung.

Alfred Baumeler، الذي يشغل منصب رئيس ومدير في Synergy CHC Corp. (SNYR)، أبلغ عن منحة خيار أسهم في 18/09/2025. المنحة هي لـ 150,000 خيار لشراء أسهم عادية بسعر تمارين قدره $2.38 للسهم. تشير الملفات إلى امتلاك 150,000 سهماً بشكل مستفاد بعد الصفقة وتسجيل الملكية كـ مباشر. تاريخ انتهاء الخيار يظهر كـ 18/09/2030. تستحق المنحة ثلثاً في الذكرى الأولى لتاريخ المنحة وتستحق الثلثان المتبقيان بالتقسيط الشهري المتساوي طوال الـ 24 شهراً التالية، رهناً بالاستمرار في الخدمة.

Alfred Baumeler,作为 Synergy CHC Corp.(SNYR)的 总裁兼董事,已在 2025/09/18 报告了一项股票期权授予。该授予为 150,000 份购买普通股的期权,行使价格为每股 $2.38。申报文件在交易后列出 150,000 股的受益所有权,并将所有权记载为 直接。该期权的到期日显示为 09/18/2030。该授予在授予日期的第一周年时归属三分之一,其余三分之二在随后的 24 个月内按月等额归属,前提是持续任职。

Positive
  • 150,000 option grant disclosed with explicit terms (exercise price and expiration) providing transparency
  • Vesting schedule is specified: one‑third after one year, remainder vesting monthly over 24 months, subject to continued service
  • Direct beneficial ownership of 150,000 options is reported, showing clear alignment with company equity
Negative
  • None.

Insights

TL;DR: Executive received a time‑based option grant that ties compensation to continued service and potential future share value.

The reported Form 4 documents a standard service‑conditioned stock option: 150,000 options at $2.38 with an explicit multi‑year vesting schedule and a 09/18/2030 expiration. From a governance perspective, the grant aligns the reporting person’s interests with long‑term shareholder value by requiring continued service to vest. The form shows direct ownership and proper Section 16 reporting protocol, signed by an attorney‑in‑fact on 09/22/2025.

TL;DR: The award is a conventional time‑vesting stock option, providing potential upside if share price rises above $2.38 before expiration.

The schedule—one‑third after one year, then monthly over 24 months—creates a three‑year full vesting horizon which is common for retention and performance alignment. Key specifics available in the filing are the grant size (150,000 options), exercise price ($2.38), transaction date (09/18/2025) and expiration (09/18/2030). No performance conditions or accelerated vesting provisions are disclosed in the filing.

Alfred Baumeler, presidente e un Direttore di Synergy CHC Corp. (SNYR), ha riportato una concessione di stock option in data 09/18/2025. L'assegnazione riguarda 150,000 opzioni per l'acquisto di azioni ordinarie a un prezzo di esercizio di $2.38 per azione. La pratica riporta 150,000 azioni detenute beneficiariamente dopo la transazione e registra la proprietà come diretta. L'opzione ha una data di scadenza indicata come 09/18/2030. La concessione matura un terzo al primo anniversario della data di concessione e i restanti due terzi maturano in rate mensili uguali nei 24 mesi successivi, soggetti al proseguimento del servizio.

Alfred Baumeler, quien se desempeña como Presidente y Director de Synergy CHC Corp. (SNYR), informó una concesión de opciones sobre acciones el 18/09/2025. La concesión es de 150,000 opciones para comprar acciones comunes a un precio de ejercicio de $2.38 por acción. El informe indica que, tras la transacción, se poseen 150,000 acciones de forma beneficiosa y registra la propiedad como directa. La opción tiene una fecha de vencimiento que aparece como 09/18/2030. La concesión se consolida en un tercio al primer aniversario de la fecha de concesión y los dos tercios restantes se consolidan en cuotas mensuales iguales durante los 24 meses siguientes, sujeto a la continuación del servicio.

Alfred Baumeler는 Synergy CHC Corp. (SNYR)의 회장이자 이사로 재직 중이며 2025년 9월 18일에 주식 매수 옵션 부여를 보고했습니다. 이 부여는 150,000개의 일반 주식 매수를 위한 옵션이며 행사 가격은 주당 $2.38입니다. 신고서는 거래 후 150,000주를 유리하게 보유하고 있으며 소유권을 직접으로 기록합니다. 옵션의 만료 날짜는 2025년 9월 18일로 표시됩니다. 부여는 그랜트일의 첫 기념일에 3분의 1이 귀속되고 나머지 2분의 1은 이후 24개월 동안 매월 균등하게 귀속되며 지속적으로 근무하는 조건에 따릅니다.

Alfred Baumeler, qui occupe le poste de président et administrateur de Synergy CHC Corp. (SNYR), a signalé l'attribution d'une option d'achat d'actions le 18/09/2025. L'octroi porte sur 150,000 options d'achat d'actions ordinaires à un prix d'exercice de $2.38 par action. Le dossier indique que 150,000 actions sont détenues de manière bénéficiaire à la suite de l'opération et que la propriété est enregistrée comme directe. L'option expire le 18/09/2030. L'octroi vestit en un tiers au premier anniversaire de la date d'octroi et les deux tiers restants vestissent en versements mensuels égaux sur les 24 mois qui suivent, sous réserve du maintien du service.

Alfred Baumeler, der als Präsident und Director von Synergy CHC Corp. (SNYR) fungiert, meldete eine Aktienoptionszuteilung am 18.09.2025. Die Zuteilung umfasst 150.000 Optionen zum Kauf von Stammaktien zu einem Ausübungspreis von $2.38 pro Aktie. Die Einreichung listet 150.000 anteilig gehaltene Aktien nach der Transaktion auf und vermerkt Eigentum als direkt. Die Option hat ein Ablaufdatum, das als 09/18/2030 angezeigt wird. Die Zuteilung vestiert ein Drittel am ersten Jahrestag des Gewährungsdatums, und die verbleibenden zwei Drittel vestieren in gleichen monatlichen Raten über die folgenden 24 Monate, vorbehaltlich der weiteren Beschäftigung.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Baumeler Alfred

(Last) (First) (Middle)
C/O SYNERGY CHC CORP.
865 SPRING STREET

(Street)
WESTBROOK ME 04092

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Synergy CHC Corp. [ SNYR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President
3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option (right to buy) $2.38 09/18/2025 A 150,000 (1) 09/18/2030 Common Stock, par value $0.00001 per share 150,000 $0 150,000 D
Explanation of Responses:
1. One-third (1/3) of this option grant vests on the first anniversary of the date of grant, and the remaining two-thirds (2/3) vest in equal monthly installments over the following twenty-four (24) months, subject to the reporting person's continued service with the Company.
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact 09/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Alfred Baumeler report on the Form 4 for SNYR?

The Form 4 reports a stock option grant of 150,000 options acquired on 09/18/2025 with an exercise price of $2.38.

What is the vesting schedule for the option grant reported by SNYR insider?

The grant vests one‑third on the first anniversary of the grant date and the remaining two‑thirds in equal monthly installments over the following 24 months, subject to continued service.

When do the options expire according to the Form 4?

The filing shows an expiration date of 09/18/2030 for the option grant.

What is the ownership form and amount after the reported transaction?

The ownership is reported as direct with 150,000 options beneficially owned following the transaction.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by an attorney‑in‑fact from Nelson Mullins Riley & Scarborough LLP on 09/22/2025.
Synergy Chc Corp

NASDAQ:SNYR

SNYR Rankings

SNYR Latest News

SNYR Latest SEC Filings

SNYR Stock Data

28.65M
4.84M
56.75%
3.82%
1.06%
Medical Distribution
Medicinal Chemicals & Botanical Products
Link
United States
WESTBROOK